Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE54.3600
- TODAY'S CHANGE (%)1.0200 (1.9123%)
- Bid / Lots52.3400/ 1
- Ask / Lots56.5400/ 1
- Open / Previous Close54.2400 / 53.3400
- Day Range
- 52 Week Range
- Volume541,345
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 4210 | 54.19 |
| 09:36 ET | 300 | 54 |
| 09:38 ET | 754 | 54 |
| 09:41 ET | 100 | 54.15 |
| 09:43 ET | 800 | 54.285 |
| 09:45 ET | 2600 | 54.48 |
| 09:48 ET | 5326 | 54.69 |
| 09:50 ET | 400 | 54.685 |
| 09:52 ET | 500 | 54.745 |
| 09:56 ET | 5059 | 54.93 |
| 09:57 ET | 362 | 54.83 |
| 09:59 ET | 2200 | 54.665 |
| 10:01 ET | 700 | 54.685 |
| 10:03 ET | 1200 | 54.56 |
| 10:06 ET | 1053 | 54.43 |
| 10:08 ET | 1100 | 54.54 |
| 10:10 ET | 2161 | 54.335 |
| 10:12 ET | 900 | 54.4 |
| 10:14 ET | 2305 | 54.26 |
| 10:15 ET | 500 | 54.2 |
| 10:17 ET | 10340 | 54.24 |
| 10:19 ET | 645 | 54.05 |
| 10:21 ET | 200 | 54.01 |
| 10:24 ET | 100 | 54.01 |
| 10:26 ET | 800 | 54.12 |
| 10:28 ET | 300 | 54.06 |
| 10:30 ET | 4914 | 53.69 |
| 10:32 ET | 700 | 53.55 |
| 10:33 ET | 1004 | 53.585 |
| 10:35 ET | 400 | 53.605 |
| 10:37 ET | 200 | 53.55 |
| 10:39 ET | 1700 | 53.98 |
| 10:42 ET | 626 | 54.055 |
| 10:44 ET | 400 | 54.07 |
| 10:46 ET | 1600 | 54.005 |
| 10:48 ET | 407 | 53.8524 |
| 10:50 ET | 635 | 53.85 |
| 10:51 ET | 700 | 53.86 |
| 10:53 ET | 400 | 53.7 |
| 10:55 ET | 300 | 53.705 |
| 10:57 ET | 1000 | 53.8 |
| 11:00 ET | 100 | 53.82 |
| 11:02 ET | 200 | 53.65 |
| 11:04 ET | 1800 | 53.74 |
| 11:06 ET | 11800 | 53.835 |
| 11:08 ET | 400 | 53.81 |
| 11:09 ET | 308 | 53.935 |
| 11:11 ET | 695 | 53.82 |
| 11:13 ET | 700 | 53.8 |
| 11:15 ET | 100 | 53.83 |
| 11:18 ET | 1200 | 53.755 |
| 11:20 ET | 200 | 53.7 |
| 11:22 ET | 500 | 53.755 |
| 11:24 ET | 900 | 53.83 |
| 11:26 ET | 100 | 53.9 |
| 11:27 ET | 100 | 53.9 |
| 11:29 ET | 200 | 53.98 |
| 11:31 ET | 800 | 53.99 |
| 11:36 ET | 893 | 54 |
| 11:38 ET | 1473 | 54.0674 |
| 11:42 ET | 100 | 54.105 |
| 11:44 ET | 700 | 54.08 |
| 11:45 ET | 2013 | 54.33 |
| 11:47 ET | 3576 | 54.41 |
| 11:49 ET | 2205 | 54.19 |
| 11:51 ET | 400 | 54.12 |
| 11:54 ET | 100 | 54.09 |
| 11:56 ET | 100 | 53.95 |
| 11:58 ET | 400 | 54.14 |
| 12:00 ET | 500 | 54.235 |
| 12:02 ET | 300 | 54.08 |
| 12:03 ET | 2363 | 54.05 |
| 12:05 ET | 100 | 54.035 |
| 12:07 ET | 200 | 54.02 |
| 12:09 ET | 1300 | 54.03 |
| 12:12 ET | 335 | 53.9734 |
| 12:14 ET | 100 | 54 |
| 12:16 ET | 1364 | 54.07 |
| 12:18 ET | 300 | 53.95 |
| 12:20 ET | 200 | 54 |
| 12:21 ET | 300 | 53.94 |
| 12:23 ET | 200 | 53.69 |
| 12:25 ET | 4401 | 53.87 |
| 12:27 ET | 400 | 53.91 |
| 12:30 ET | 1292 | 53.82 |
| 12:32 ET | 691 | 53.87 |
| 12:34 ET | 100 | 53.935 |
| 12:36 ET | 500 | 53.875 |
| 12:38 ET | 900 | 53.905 |
| 12:39 ET | 100 | 53.905 |
| 12:41 ET | 200 | 53.915 |
| 12:43 ET | 2498 | 54.01 |
| 12:45 ET | 519 | 53.93 |
| 12:48 ET | 300 | 54 |
| 12:50 ET | 2502 | 53.925 |
| 12:52 ET | 200 | 53.8 |
| 12:54 ET | 424 | 53.8 |
| 12:56 ET | 400 | 53.75 |
| 12:57 ET | 300 | 53.75 |
| 12:59 ET | 100 | 53.8 |
| 01:03 ET | 804 | 53.93 |
| 01:06 ET | 100 | 53.87 |
| 01:08 ET | 1000 | 53.93 |
| 01:10 ET | 200 | 53.885 |
| 01:12 ET | 1000 | 54 |
| 01:14 ET | 525 | 53.9585 |
| 01:15 ET | 900 | 54 |
| 01:17 ET | 900 | 53.9 |
| 01:21 ET | 100 | 53.92 |
| 01:24 ET | 1700 | 53.91 |
| 01:26 ET | 500 | 53.97 |
| 01:28 ET | 100 | 54.04 |
| 01:30 ET | 200 | 54.03 |
| 01:32 ET | 200 | 54 |
| 01:33 ET | 481 | 54 |
| 01:35 ET | 1351 | 53.94 |
| 01:37 ET | 1435 | 53.915 |
| 01:39 ET | 200 | 53.765 |
| 01:42 ET | 3522 | 53.96 |
| 01:46 ET | 2351 | 54.03 |
| 01:48 ET | 300 | 54.19 |
| 01:51 ET | 4744 | 54.19 |
| 01:53 ET | 200 | 54.24 |
| 01:55 ET | 840 | 54.19 |
| 01:57 ET | 1800 | 54.21 |
| 02:02 ET | 300 | 54.2 |
| 02:04 ET | 3400 | 54.19 |
| 02:06 ET | 376 | 54.2299 |
| 02:08 ET | 500 | 54.09 |
| 02:11 ET | 1452 | 54.24 |
| 02:13 ET | 3742 | 54.22 |
| 02:15 ET | 200 | 54.22 |
| 02:20 ET | 607 | 54.25 |
| 02:22 ET | 500 | 54.225 |
| 02:24 ET | 1300 | 54.24 |
| 02:26 ET | 3711 | 54.16 |
| 02:27 ET | 394 | 54.22 |
| 02:31 ET | 500 | 54.16 |
| 02:33 ET | 300 | 54.14 |
| 02:36 ET | 200 | 54.21 |
| 02:38 ET | 1100 | 54.215 |
| 02:40 ET | 700 | 54.25 |
| 02:42 ET | 1364 | 54.15 |
| 02:44 ET | 200 | 54.12 |
| 02:45 ET | 1311 | 54.12 |
| 02:47 ET | 600 | 54.145 |
| 02:49 ET | 600 | 54.2 |
| 02:51 ET | 800 | 54.27 |
| 02:54 ET | 100 | 54.34 |
| 02:56 ET | 1252 | 54.12 |
| 02:58 ET | 2294 | 54.285 |
| 03:00 ET | 1587 | 54.3 |
| 03:02 ET | 200 | 54.27 |
| 03:03 ET | 945 | 54.27 |
| 03:05 ET | 950 | 54.2 |
| 03:07 ET | 3943 | 54.2 |
| 03:09 ET | 744 | 54.26 |
| 03:12 ET | 100 | 54.25 |
| 03:14 ET | 2458 | 54.33 |
| 03:16 ET | 1100 | 54.21 |
| 03:18 ET | 748 | 54.21 |
| 03:20 ET | 700 | 54.22 |
| 03:21 ET | 200 | 54.24 |
| 03:23 ET | 1984 | 54.25 |
| 03:25 ET | 3821 | 54.36 |
| 03:27 ET | 1845 | 54.4 |
| 03:30 ET | 900 | 54.375 |
| 03:32 ET | 1002 | 54.3 |
| 03:34 ET | 3339 | 54.27 |
| 03:36 ET | 4393 | 54.45 |
| 03:38 ET | 3200 | 54.29 |
| 03:39 ET | 2678 | 54.3112 |
| 03:41 ET | 2210 | 54.29 |
| 03:43 ET | 1648 | 54.28 |
| 03:45 ET | 1600 | 54.27 |
| 03:48 ET | 4667 | 54.425 |
| 03:50 ET | 2077 | 54.35 |
| 03:52 ET | 9615 | 54.4 |
| 03:54 ET | 6286 | 54.2925 |
| 03:56 ET | 7986 | 54.27 |
| 03:57 ET | 8426 | 54.39 |
| 03:59 ET | 120428 | 54.36 |
Jul 18, 2024
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024, from 4:05PM ET on Thursday Jul 18, 2024 by Dow Jones
4:05PM ET on Thursday Jul 18, 2024 by Dow Jones
Jul 10, 2024
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:29PM ET on Wednesday Jul 10, 2024 by Dow Jones
7:29PM ET on Wednesday Jul 10, 2024 by Dow Jones
Jul 9, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Overweight by JP Morgan, from 11:09AM ET on Tuesday Jul 09, 2024 by Dow Jones
11:09AM ET on Tuesday Jul 09, 2024 by Dow Jones
Jul 2, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Overweight by Piper Sandler, from 1:39PM ET on Tuesday Jul 02, 2024 by Dow Jones
1:39PM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 28, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 6:57AM ET on Friday Jun 28, 2024 by Dow Jones
6:57AM ET on Friday Jun 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.2B | -14.4x | --- |
Dyne Therapeutics Inc | 4.2B | -11.2x | --- |
Immunovant Inc | 4.1B | -15.4x | --- |
Immunitybio Inc | 3.8B | -5.3x | --- |
Avidity Biosciences Inc | 4.7B | -16.3x | --- |
Biohaven Ltd | 3.6B | -6.0x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.4x |
Price/Sales (TTM) | 2,130.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
